Georgio Walter Canonica
University of Medicine, Genoa, Italy
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Georgio Walter Canonica as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:58 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT02676089 · TRIple in Asthma hiGh strenGth vErsus Ics/Laba hs and tiotRopium (TRIGGER)Chiesi Farmaceutici S.p.A. · completed · Asthma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:58 UTC. The ranking covers the 200 most relevant of 120 PubMed records, and a shared surname and initials can bring in a namesake. All 120 on PubMed
- 1,284 citationsRCR 71.4
- 839 citationsRCR 22.4
- 261 citationsRCR 7.2
- Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study.J Allergy Clin Immunol · 2010254 citationsRCR 8.5
- Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study.Clin Exp Allergy · 2003241 citationsRCR 7.5
- Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial.J Allergy Clin Immunol · 2014217 citationsRCR 8.4
- 213 citationsRCR 7.4
- 177 citationsRCR 10.1
- Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study.Ann Allergy Asthma Immunol · 2008172 citationsRCR 5.9
- Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis.J Allergy Clin Immunol · 1999167 citationsRCR 6.0